Canadian manufacturer Medicago says its COVID-19 vaccine shows promise in trials

Although the data still needs to be scrutinized, Quebec company Medicago says its latest trial suggests the COVID-19 vaccine it’s produced with GlaxoSmithKline is showing promise. Jamie Mauracher explains where the Canadian-made shot is now in the approval process, and its implications beyond this country.

• Canadian manufacturer Medicago’s COVID-19 vaccine showing strong efficacy